Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.

Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.

Item
http://www.wikidata.org/entity/Q34990620
Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewCD36 inhibitors reduce postprandial hypertriglyceridemia and protect against diabetic dyslipidemia and atherosclerosisA Dietary Pattern Derived by Reduced Rank Regression is Associated with Type 2 Diabetes in An Urban Ghanaian Population.Increased tissue factor, MMP-8, and D-dimer expression in diabetic patients with unstable advanced carotid atherosclerosis.Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles.The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN studyboxs.Lipids and lipoprotein ratios: contribution to carotid intima media thickness in adolescents and young adults with type 2 diabetes mellitusDiabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients.Bromocriptine--unique formulation of a dopamine agonist for the treatment of type 2 diabetes.Increased CD36 protein as a response to defective insulin signaling in macrophagesTauroursodeoxycholic acid attenuates lipid accumulation in endoplasmic reticulum-stressed macrophages.beta-Agonist stimulation produces changes in cardiac AMPK and coronary lumen LPL only during increased workload.Cleavage of protein kinase D after acute hypoinsulinemia prevents excessive lipoprotein lipase-mediated cardiac triglyceride accumulation.Endothelial heparanase secretion after acute hypoinsulinemia is regulated by glucose and fatty acid.Elevation of small, dense low density lipoprotein cholesterol-a possible antecedent of atherogenic lipoprotein phenotype in type 2 diabetes patients in Jos, North-Central Nigeria.Dual effects of hyperglycemia on endothelial cells and cardiomyocytes to enhance coronary LPL activity.Endothelial cells respond to hyperglycemia by increasing the LPL transporter GPIHBP1.
P2860

Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.

Item
http://www.wikidata.org/entity/Q34990620
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.
@ast
Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.
@en
Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.
@nl
type
label
Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.
@ast
Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.
@en
Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.
@nl
prefLabel
Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.
@ast
Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.
@en
Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.
@en
P2093
P304
P31
P356
10.1016/S0002-9149(02)02634-6
P407
P433
P478
P577
P698
P921